Autoimmune hepatitis. Part A: pathogenesis (Q37346054)

19 August 2017

1 reference

title

Autoimmune hepatitis. Part A: pathogenesis (English)

1 reference

19 August 2017

0 references

Albert J Czaja

1

1 reference

19 August 2017

publication date

1 October 2007

1 reference

Expert Review of Gastroenterology & Hepatology

19 August 2017

published in

1 reference

19 August 2017

volume

1

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

113-128

1 reference

Diagnosis and treatment of autoimmune hepatitis

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Autoimmune hepatitis, from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Understanding the pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Genetic bases of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Apoptosis and the liver: relation to autoimmunity and related conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

T cell immunity in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Fas polymorphisms influence susceptibility to autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

MHC-independent genetic regulation of liver damage in a mouse model of autoimmune hepatocellular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Detection of autoimmune regulator gene mutations in children with type 2 autoimmune hepatitis and extrahepatic immune-mediated diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

cDNA microarray analysis of autoimmune hepatitis, primary biliary cirrhosis and consecutive disease manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Glycolipids as immune modulatory tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Critical contribution of liver natural killer T cells to a murine model of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

The gamma delta T cell receptor and class Ib MHC-related proteins: enigmatic molecules of immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Chemokines in the systemic organization of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Molecular mimicry and autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Immune phenotype of chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Autoimmunity and the female liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

A gender gap in autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Epidemiology and estimated population burden of selected autoimmune diseases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

A Structural Model for TCR Recognition of the HLA Class II Shared Epitope Sequence Implicated in Susceptibility to Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.1.1.113

21 January 2018

Identifiers

DOI

10.1586/17474124.1.1.113

1 reference

19 August 2017

1 reference